Insulet Corporation

PODDNASDAQHealthcare● Active

$152.67

$-0.55(-0.36%)

Market Cap$10.6B

P/E Ratio—

52W High$354.88

52W Low$140.63

Avg Volume1.3M

Open$151.98

Beta1.13

Overview

Insulet Corporation (PODD) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

PODD · free cash flow · updated Jun 8, 2026

Core FCF metrics

PODD · FCF · TTM · margin & CAGR

Free cash flow was $377.7M for FY2025 (fiscal year ending 2025-12-31), up 23.7% year-over-year The FCF margin was 13.9%.

FY2025 Free Cash Flow$377.7M▲ +23.7% YoY

Trailing 12M (TTM)$412.2Mtrailing 4 quarters sum

FCF Margin13.9%$377.7M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

PODD · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$569.3M(192M)$377.7M▲ +23.7%13.9%

FY2024$430.3M(125M)$305.4M▲ +335.7%14.7%

FY2023$145.7M(76M)$70.1M▲ +283.0%4.1%

FY2022$119.0M(157M)−$38.3M▲ +79.9%-2.9%

FY2021−$68.1M(123M)−$190.8M▼ 131.3%-17.4%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

PODD · P/FCF · FCF yield · FCF per share

Insulet Corporation (PODD) trades at a FCF yield of 3.91% and a price-to-free-cash-flow ratio of 26.1x. FCF per share stands at $5.86, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

3.91%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$5.86

TTM FCF ÷ Shares Outstanding

Price / FCF

x26.1

Share Price ÷ FCF per Share

EV / FCF (TTM)

x26.7

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

PODD · cash flow statement · operating / investing / financing

For FY2025, Insulet Corporation generated $569.3M in operating cash flow and spent 192M in capital expenditures, yielding $377.7M in free cash flow.

Operating Activities

+$569.3M

Cash from core business operations

2025-12-31

Investing Activities

−$222.7M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$595.3M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($569.3M) − |CapEx| (192M) = FCF ($377.7M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

PODD vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Insulet CorporationYOU

PODD

$377.7M+23.7%13.9%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Insulet Corporation (PODD) reported free cash flow of $377.7M for FY2025 (fiscal year ending 2025-12-31), up 23.7% year-over-year. The FCF margin was 13.9%.

Based on available data, Insulet Corporation has maintained positive free cash flow for at least 3 fiscal year(s). FCF peaked at $377.7M in FY2025.

Insulet Corporation's FCF yield is 3.91% and price-to-FCF ratio is 26.1x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

PODD free cash flow · 8 questions

Insulet Corporation free cash flow was $377.7M for FY2025, up 23.7% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $412.2M.

PODD free cash flowPODD FCFPODD FCF 2025PODD free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Insulet Corporation · Insulet Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026